CAS 1337878-62-2

Formule : C104H178N26O25S2

InChI : InChI=1S/C104H178N26O25S2/c1-9-10-11-12-13-14-15-16-17-18-19-20-21-35-84(136)116-75(46-53-156-7)88(140)115-60-85(137)117-78(57-65-36-40-67(133)41-37-65)97(149)123-74(44-45-83(108)135)94(146)119-69(30-22-25-48-105)89(141)118-70(31-23-26-49-106)90(142)125-77(55-62(2)3)96(148)121-73(34-29-52-114-104(111)112)93(145)129-82(61-131)100(152)124-76(47-54-157-8)95(147)130-87(64(6)132)101(153)127-80(59-86(138)139)99(151)120-71(32-24-27-50-107)91(143)126-79(58-66-38-42-68(134)43-39-66)98(150)122-72(33-28-51-113-103(109)110)92(144)128-81(102(154)155)56-63(4)5/h36-43,62-64,69-82,87,131-134H,9-35,44-61,105-107H2,1-8H3,(H2,108,135)(H,115,140)(H,116,136)(H,117,137)(H,118,141)(H,119,146)(H,120,151)(H,121,148)(H,122,150)(H,123,149)(H,124,152)(H,125,142)(H,126,143)(H,127,153)(H,128,144)(H,129,145)(H,130,147)(H,138,139)(H,154,155)(H4,109,110,113)(H4,111,112,114)/t64-,69+,70+,71+,72+,73+,74+,75+,76+,77+,78+,79+,80+,81+,82+,87+/m1/s1

Code InChI : YMLOFEANRZSEGQ-QNHYGVTPSA-N

SMILES : CCCCCCCCCCCCCCCC(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O

ATI-2341

CAS : 1337878-62-2

ATI-2341, pepducin targeting the CXCR4, is an allosteric agonist activating the Gi to promote inhibition of cAMP production and induce calcium mobilization.

Formule : C₁₀₄H₁₇₈N₂₆O₂₅S₂

Couleur et forme : Solid

Masse moléculaire : 2256.82

Ref: TM-T6764

ATI-2341

CAS : 1337878-62-2

Formule : C₁₀₄H₁₇₈N₂₆O₂₅S₂

Degré de pureté : 98%

Masse moléculaire : 2256.8153

Ref: IN-DA01ENEW

ATI 2341

CAS : 1337878-62-2

ATI 2341 is a colony-stimulating factor that belongs to the group of pharmaceutical drugs. It is used in cancer diagnosis and treatment, as well as for the prevention of chemotherapy-induced neutropenia. ATI 2341 is a chemokine that binds to the chemokine receptors CXCR4 and CXCR7. ATI 2341 has an inhibitory effect on chemotaxis and inflammatory activity in macrophages. This drug also has a heteromeric complex with other chemokines, such as IL-8, MCP-1, or MIP-1α. ATI 2341 interacts with these other chemokines by binding to their specific agonists, which are found on human immunodeficiency virus (HIV) section cells or cancer cells.

Formule : C₁₀₄H₁₇₈N₂₆O₂₅S₂

Degré de pureté : Min. 95%

Masse moléculaire : 2,256.82 g/mol

Ref: 3D-MDC87862